

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein heterotrimerization (GO:0070208) | 7.43896782 |
| 2 | extracellular fibril organization (GO:0043206) | 5.98722044 |
| 3 | fibril organization (GO:0097435) | 5.14777994 |
| 4 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.03132016 |
| 5 | keratan sulfate catabolic process (GO:0042340) | 4.91575653 |
| 6 | * collagen fibril organization (GO:0030199) | 4.77603793 |
| 7 | cell migration involved in heart development (GO:0060973) | 4.72756088 |
| 8 | positive regulation of fatty acid oxidation (GO:0046321) | 4.49844746 |
| 9 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.42898640 |
| 10 | collagen metabolic process (GO:0032963) | 4.23205035 |
| 11 | multicellular organismal macromolecule metabolic process (GO:0044259) | 4.13538512 |
| 12 | low-density lipoprotein particle clearance (GO:0034383) | 4.13066657 |
| 13 | collagen catabolic process (GO:0030574) | 4.06390348 |
| 14 | multicellular organismal metabolic process (GO:0044236) | 4.01166033 |
| 15 | regulation of sequestering of triglyceride (GO:0010889) | 3.92105967 |
| 16 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.90044412 |
| 17 | multicellular organismal catabolic process (GO:0044243) | 3.84543855 |
| 18 | fatty acid transmembrane transport (GO:1902001) | 3.80784211 |
| 19 | extracellular matrix assembly (GO:0085029) | 3.75639238 |
| 20 | carnitine shuttle (GO:0006853) | 3.74433380 |
| 21 | blood vessel maturation (GO:0001955) | 3.73086147 |
| 22 | dermatan sulfate biosynthetic process (GO:0030208) | 3.72657999 |
| 23 | cellular response to vitamin (GO:0071295) | 3.70390927 |
| 24 | bone trabecula formation (GO:0060346) | 3.70316760 |
| 25 | glycerolipid catabolic process (GO:0046503) | 3.69585968 |
| 26 | barbed-end actin filament capping (GO:0051016) | 3.68157545 |
| 27 | transcytosis (GO:0045056) | 3.64794423 |
| 28 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62032562 |
| 29 | metanephric mesenchyme development (GO:0072075) | 3.59771198 |
| 30 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.56601676 |
| 31 | negative regulation of heart growth (GO:0061117) | 3.54895208 |
| 32 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.54895208 |
| 33 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.54253318 |
| 34 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.52444504 |
| 35 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.50294327 |
| 36 | ovulation from ovarian follicle (GO:0001542) | 3.49996431 |
| 37 | regulation of fatty acid oxidation (GO:0046320) | 3.48162075 |
| 38 | glomerular filtration (GO:0003094) | 3.47037209 |
| 39 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.46304160 |
| 40 | ethanol oxidation (GO:0006069) | 3.44915468 |
| 41 | protein localization to cell surface (GO:0034394) | 3.43491762 |
| 42 | stress fiber assembly (GO:0043149) | 3.42420586 |
| 43 | dermatan sulfate metabolic process (GO:0030205) | 3.40731700 |
| 44 | extracellular matrix disassembly (GO:0022617) | 3.40689322 |
| 45 | venous blood vessel morphogenesis (GO:0048845) | 3.39379699 |
| 46 | brown fat cell differentiation (GO:0050873) | 3.38897258 |
| 47 | cGMP-mediated signaling (GO:0019934) | 3.37808266 |
| 48 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.37024942 |
| 49 | basement membrane organization (GO:0071711) | 3.34634766 |
| 50 | glomerular basement membrane development (GO:0032836) | 3.34330133 |
| 51 | endocrine hormone secretion (GO:0060986) | 3.33353467 |
| 52 | response to dietary excess (GO:0002021) | 3.33017880 |
| 53 | kidney mesenchyme development (GO:0072074) | 3.32201494 |
| 54 | lipid particle organization (GO:0034389) | 3.31358046 |
| 55 | NADH metabolic process (GO:0006734) | 3.30511806 |
| 56 | regulation of phospholipase A2 activity (GO:0032429) | 3.26299801 |
| 57 | polyol transport (GO:0015791) | 3.25063470 |
| 58 | negative regulation of granulocyte differentiation (GO:0030853) | 3.22259504 |
| 59 | adhesion of symbiont to host (GO:0044406) | 3.22236346 |
| 60 | apoptotic cell clearance (GO:0043277) | 3.18606087 |
| 61 | triglyceride catabolic process (GO:0019433) | 3.16525527 |
| 62 | renal filtration (GO:0097205) | 3.14772686 |
| 63 | plasma membrane repair (GO:0001778) | 3.14726767 |
| 64 | cellular response to epinephrine stimulus (GO:0071872) | 3.13573178 |
| 65 | skin morphogenesis (GO:0043589) | 3.10758829 |
| 66 | regulation of gonadotropin secretion (GO:0032276) | 3.09734281 |
| 67 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.09727889 |
| 68 | positive regulation of macrophage cytokine production (GO:0060907) | 3.08831049 |
| 69 | lipid storage (GO:0019915) | 3.08302361 |
| 70 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.06964777 |
| 71 | endodermal cell differentiation (GO:0035987) | 3.05429849 |
| 72 | positive regulation of cholesterol efflux (GO:0010875) | 3.05105263 |
| 73 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.04630437 |
| 74 | regulation of skeletal muscle contraction (GO:0014819) | 3.03403819 |
| 75 | peptide cross-linking (GO:0018149) | 3.02508597 |
| 76 | cell proliferation involved in metanephros development (GO:0072203) | 3.00709984 |
| 77 | negative regulation of complement activation (GO:0045916) | 2.98377475 |
| 78 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.97400680 |
| 79 | regulation of cholesterol storage (GO:0010885) | 2.95819905 |
| 80 | fatty acid homeostasis (GO:0055089) | 2.92319402 |
| 81 | white fat cell differentiation (GO:0050872) | 2.92086030 |
| 82 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.91755432 |
| 83 | regulation of plasminogen activation (GO:0010755) | 2.91093358 |
| 84 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.90070699 |
| 85 | regulation of macrophage cytokine production (GO:0010935) | 2.89862708 |
| 86 | valine metabolic process (GO:0006573) | 2.89628669 |
| 87 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.89368564 |
| 88 | axon extension involved in axon guidance (GO:0048846) | 2.89368564 |
| 89 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.86711031 |
| 90 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.86657330 |
| 91 | trabecula formation (GO:0060343) | 2.84093240 |
| 92 | endothelial cell morphogenesis (GO:0001886) | 2.84014872 |
| 93 | negative regulation of protein autophosphorylation (GO:0031953) | 2.82156981 |
| 94 | positive regulation of glycogen metabolic process (GO:0070875) | 2.81902945 |
| 95 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.81613029 |
| 96 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.81468694 |
| 97 | carnitine transmembrane transport (GO:1902603) | 2.80672818 |
| 98 | muscle filament sliding (GO:0030049) | 2.80268198 |
| 99 | actin-myosin filament sliding (GO:0033275) | 2.80268198 |
| 100 | positive regulation of lipid storage (GO:0010884) | 2.80266155 |
| 101 | negative regulation of gluconeogenesis (GO:0045721) | 2.79912236 |
| 102 | biotin metabolic process (GO:0006768) | 2.79305601 |
| 103 | cardiac myofibril assembly (GO:0055003) | 2.79154379 |
| 104 | acylglycerol catabolic process (GO:0046464) | 2.78463020 |
| 105 | neutral lipid catabolic process (GO:0046461) | 2.78463020 |
| 106 | regulation of p38MAPK cascade (GO:1900744) | 2.76968589 |
| 107 | lymph vessel development (GO:0001945) | 2.76770174 |
| 108 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.76642364 |
| 109 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.76447271 |
| 110 | hemidesmosome assembly (GO:0031581) | 2.75013834 |
| 111 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.72687650 |
| 112 | diacylglycerol metabolic process (GO:0046339) | 2.72127440 |
| 113 | ethanol metabolic process (GO:0006067) | 2.71695117 |
| 114 | positive regulation of glucose import (GO:0046326) | 2.69829416 |
| 115 | regulation of lipoprotein metabolic process (GO:0050746) | 2.68358069 |
| 116 | peripheral nervous system axon ensheathment (GO:0032292) | 2.68245955 |
| 117 | myelination in peripheral nervous system (GO:0022011) | 2.68245955 |
| 118 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.67443338 |
| 119 | phagocytosis, recognition (GO:0006910) | 2.66839385 |
| 120 | positive regulation of metanephros development (GO:0072216) | 2.66329283 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64441190 |
| 122 | * extracellular matrix organization (GO:0030198) | 2.64290634 |
| 123 | complement activation, alternative pathway (GO:0006957) | 2.63697330 |
| 124 | negative regulation of macrophage differentiation (GO:0045650) | 2.63627769 |
| 125 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.63345356 |
| 126 | * extracellular structure organization (GO:0043062) | 2.63035217 |
| 127 | response to epinephrine (GO:0071871) | 2.62834458 |
| 128 | positive regulation of p38MAPK cascade (GO:1900745) | 2.62373051 |
| 129 | fatty acid beta-oxidation (GO:0006635) | 2.61868300 |
| 130 | positive regulation of glycolytic process (GO:0045821) | 2.61661287 |
| 131 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.61446602 |
| 132 | endothelium development (GO:0003158) | 2.60789027 |
| 133 | heart trabecula formation (GO:0060347) | 2.59117838 |
| 134 | positive regulation of sterol transport (GO:0032373) | 2.58176027 |
| 135 | positive regulation of cholesterol transport (GO:0032376) | 2.58176027 |
| 136 | growth hormone receptor signaling pathway (GO:0060396) | 2.57481120 |
| 137 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.53208532 |
| 138 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.53208532 |
| 139 | carnitine transport (GO:0015879) | 2.52403685 |
| 140 | amino-acid betaine transport (GO:0015838) | 2.52403685 |
| 141 | actin-mediated cell contraction (GO:0070252) | 2.50245784 |
| 142 | adhesion of symbiont to host cell (GO:0044650) | 2.49754566 |
| 143 | virion attachment to host cell (GO:0019062) | 2.49754566 |
| 144 | positive regulation of osteoblast proliferation (GO:0033690) | 2.48677311 |
| 145 | fibroblast migration (GO:0010761) | 2.48397127 |
| 146 | myofibril assembly (GO:0030239) | 2.48253163 |
| 147 | negative regulation of cartilage development (GO:0061037) | 2.47073896 |
| 148 | protein trimerization (GO:0070206) | 2.45827820 |
| 149 | sulfur compound catabolic process (GO:0044273) | 2.45329361 |
| 150 | chondroitin sulfate catabolic process (GO:0030207) | 2.44386325 |
| 151 | positive regulation of glomerulus development (GO:0090193) | 2.43727479 |
| 152 | cardiac muscle cell proliferation (GO:0060038) | 2.40499612 |
| 153 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.39036286 |
| 154 | negative regulation of protein activation cascade (GO:2000258) | 2.37713420 |
| 155 | positive regulation of fat cell differentiation (GO:0045600) | 2.37235874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.20714105 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.35704885 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.90216018 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.69145394 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.55591084 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.07233868 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.03310875 |
| 8 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.73164002 |
| 9 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.67012623 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.37434970 |
| 11 | CJUN_26792858_Chip-Seq_BT549_Human | 2.20613054 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.18805250 |
| 13 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.13441942 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.01037673 |
| 15 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.98526816 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95757748 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95022455 |
| 18 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.86596872 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82312121 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.76771552 |
| 21 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75458744 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.73644794 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71353622 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68374727 |
| 25 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.67811408 |
| 26 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.67811408 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.65896901 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.59822493 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.58793614 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58271988 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53308567 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51408601 |
| 33 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.50207154 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45490227 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39915035 |
| 36 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38468605 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38203904 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.36996953 |
| 39 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.36957650 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36133620 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36133620 |
| 42 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.35025274 |
| 43 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.31274217 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30649924 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28397565 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27993950 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27563480 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27542412 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25686363 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24854941 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24854941 |
| 52 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.24656813 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24384972 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22074852 |
| 55 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21175442 |
| 56 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20597123 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19498676 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19336103 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18034264 |
| 60 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17642017 |
| 61 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13819238 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13676178 |
| 63 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.10866130 |
| 64 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.09352606 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07882510 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07203937 |
| 67 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07064302 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06035311 |
| 69 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05360837 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05126367 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04421191 |
| 72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03374351 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03126839 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03126839 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02474362 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02328680 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02242400 |
| 78 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.02129542 |
| 79 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01041120 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00949186 |
| 81 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.99993249 |
| 82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99801330 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99465899 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98968053 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98765498 |
| 86 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97296531 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96584219 |
| 88 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96540728 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95072607 |
| 90 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94533845 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94342074 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.93090955 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92375433 |
| 94 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91449964 |
| 95 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90540518 |
| 96 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89901451 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89842739 |
| 98 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89102798 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88270134 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88191587 |
| 101 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88062043 |
| 102 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87723323 |
| 103 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87290301 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86693581 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85326235 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84487942 |
| 107 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.84388839 |
| 108 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84381903 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84255100 |
| 110 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84011848 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83732823 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83363157 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82732755 |
| 114 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.82425281 |
| 115 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81873221 |
| 116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.81551167 |
| 117 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.80976885 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80897933 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80748503 |
| 120 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80428403 |
| 121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.79878179 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.78537144 |
| 123 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.78219188 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77217077 |
| 125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76589071 |
| 126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75529976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 8.95559610 |
| 2 | MP0005275_abnormal_skin_tensile | 7.14381379 |
| 3 | MP0005503_abnormal_tendon_morphology | 5.91766019 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.37367764 |
| 5 | MP0001958_emphysema | 3.11827317 |
| 6 | MP0000751_myopathy | 2.89840783 |
| 7 | MP0004272_abnormal_basement_membrane | 2.60452892 |
| 8 | MP0005670_abnormal_white_adipose | 2.49765041 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.39448325 |
| 10 | MP0002108_abnormal_muscle_morphology | 2.30772396 |
| 11 | MP0003279_aneurysm | 2.20737115 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.19320782 |
| 13 | * MP0002060_abnormal_skin_morphology | 2.16931189 |
| 14 | MP0004130_abnormal_muscle_cell | 2.11844988 |
| 15 | MP0005666_abnormal_adipose_tissue | 1.99499601 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 1.79864711 |
| 17 | MP0006054_spinal_hemorrhage | 1.78740921 |
| 18 | MP0003566_abnormal_cell_adhesion | 1.74023728 |
| 19 | MP0000750_abnormal_muscle_regeneration | 1.71447971 |
| 20 | MP0005375_adipose_tissue_phenotype | 1.69545787 |
| 21 | MP0005508_abnormal_skeleton_morphology | 1.64815125 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.56416070 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.47911199 |
| 24 | MP0000749_muscle_degeneration | 1.47129868 |
| 25 | MP0000003_abnormal_adipose_tissue | 1.43895927 |
| 26 | MP0005330_cardiomyopathy | 1.40490168 |
| 27 | MP0004084_abnormal_cardiac_muscle | 1.39726224 |
| 28 | MP0004087_abnormal_muscle_fiber | 1.33070058 |
| 29 | MP0002295_abnormal_pulmonary_circulatio | 1.32725687 |
| 30 | MP0001879_abnormal_lymphatic_vessel | 1.30644251 |
| 31 | MP0005369_muscle_phenotype | 1.26859821 |
| 32 | MP0003045_fibrosis | 1.24595136 |
| 33 | MP0000343_altered_response_to | 1.19074123 |
| 34 | MP0005620_abnormal_muscle_contractility | 1.18906994 |
| 35 | MP0005023_abnormal_wound_healing | 1.18228532 |
| 36 | MP0003646_muscle_fatigue | 1.16781346 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.16065142 |
| 38 | MP0003724_increased_susceptibility_to | 1.15351277 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.13868086 |
| 40 | MP0001661_extended_life_span | 1.12473773 |
| 41 | MP0005385_cardiovascular_system_phenoty | 1.11530592 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 1.11530592 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.10249875 |
| 44 | MP0002971_abnormal_brown_adipose | 1.07494129 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.06755223 |
| 46 | MP0006138_congestive_heart_failure | 1.05018240 |
| 47 | MP0003828_pulmonary_edema | 1.04576664 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.03917699 |
| 49 | MP0008775_abnormal_heart_ventricle | 1.03881578 |
| 50 | MP0003186_abnormal_redox_activity | 1.03537255 |
| 51 | MP0002972_abnormal_cardiac_muscle | 1.02063168 |
| 52 | MP0002933_joint_inflammation | 1.00339084 |
| 53 | * MP0001243_abnormal_dermal_layer | 1.00213174 |
| 54 | MP0002166_altered_tumor_susceptibility | 0.98091630 |
| 55 | MP0009384_cardiac_valve_regurgitation | 0.97365147 |
| 56 | MP0002796_impaired_skin_barrier | 0.96438311 |
| 57 | MP0000733_abnormal_muscle_development | 0.95405286 |
| 58 | MP0005390_skeleton_phenotype | 0.95309642 |
| 59 | MP0009115_abnormal_fat_cell | 0.91626330 |
| 60 | MP0000747_muscle_weakness | 0.88654342 |
| 61 | MP0003011_delayed_dark_adaptation | 0.88154001 |
| 62 | MP0001542_abnormal_bone_strength | 0.87888924 |
| 63 | MP0004484_altered_response_of | 0.86817468 |
| 64 | MP0010630_abnormal_cardiac_muscle | 0.85581980 |
| 65 | MP0005535_abnormal_body_temperature | 0.83248841 |
| 66 | MP0002168_other_aberrant_phenotype | 0.83233805 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.82905631 |
| 68 | MP0005388_respiratory_system_phenotype | 0.82393519 |
| 69 | MP0002133_abnormal_respiratory_system | 0.82393519 |
| 70 | MP0005623_abnormal_meninges_morphology | 0.78715520 |
| 71 | MP0005595_abnormal_vascular_smooth | 0.77827487 |
| 72 | MP0000230_abnormal_systemic_arterial | 0.77341291 |
| 73 | MP0004858_abnormal_nervous_system | 0.76315866 |
| 74 | MP0003868_abnormal_feces_composition | 0.76172652 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.75479438 |
| 76 | MP0003448_altered_tumor_morphology | 0.75461579 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.75431364 |
| 78 | MP0005164_abnormal_response_to | 0.74764248 |
| 79 | MP0009250_abnormal_appendicular_skeleto | 0.74607830 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 0.73691697 |
| 81 | MP0003690_abnormal_glial_cell | 0.73615839 |
| 82 | MP0005334_abnormal_fat_pad | 0.72967697 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.72709475 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 0.72210649 |
| 85 | MP0002006_tumorigenesis | 0.72159427 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.70278170 |
| 87 | MP0003252_abnormal_bile_duct | 0.68607339 |
| 88 | * MP0010771_integument_phenotype | 0.67624262 |
| 89 | MP0000163_abnormal_cartilage_morphology | 0.66995935 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.66711382 |
| 91 | MP0005448_abnormal_energy_balance | 0.66137721 |
| 92 | MP0002269_muscular_atrophy | 0.65917912 |
| 93 | MP0002128_abnormal_blood_circulation | 0.65073006 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.64600695 |
| 95 | MP0003300_gastrointestinal_ulcer | 0.64557061 |
| 96 | MP0004883_abnormal_blood_vessel | 0.64291512 |
| 97 | MP0002254_reproductive_system_inflammat | 0.63413437 |
| 98 | MP0003115_abnormal_respiratory_system | 0.63303000 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 0.62969223 |
| 100 | MP0001614_abnormal_blood_vessel | 0.62700894 |
| 101 | MP0002970_abnormal_white_adipose | 0.61030131 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.60644942 |
| 103 | MP0002115_abnormal_skeleton_extremities | 0.60311906 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.60024670 |
| 105 | MP0003283_abnormal_digestive_organ | 0.59602944 |
| 106 | MP0004134_abnormal_chest_morphology | 0.59570980 |
| 107 | MP0001175_abnormal_lung_morphology | 0.59565780 |
| 108 | MP0000249_abnormal_blood_vessel | 0.59196355 |
| 109 | MP0002113_abnormal_skeleton_development | 0.58015876 |
| 110 | * MP0005452_abnormal_adipose_tissue | 0.57508944 |
| 111 | MP0005171_absent_coat_pigmentation | 0.57336335 |
| 112 | MP0005165_increased_susceptibility_to | 0.56959172 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.56763908 |
| 114 | MP0005647_abnormal_sex_gland | 0.56031685 |
| 115 | MP0003091_abnormal_cell_migration | 0.55872762 |
| 116 | MP0003385_abnormal_body_wall | 0.53811537 |
| 117 | MP0008004_abnormal_stomach_pH | 0.53320784 |
| 118 | MP0003959_abnormal_lean_body | 0.52706419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 7.20995440 |
| 2 | Broad metatarsal (HP:0001783) | 6.09086461 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.89354039 |
| 4 | Ankle contracture (HP:0006466) | 5.59119250 |
| 5 | Increased connective tissue (HP:0009025) | 5.38812647 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 5.17725460 |
| 7 | Aortic dissection (HP:0002647) | 4.73176371 |
| 8 | Cerebral aneurysm (HP:0004944) | 4.35081960 |
| 9 | Follicular hyperkeratosis (HP:0007502) | 4.27928704 |
| 10 | Round ear (HP:0100830) | 4.10781539 |
| 11 | Soft skin (HP:0000977) | 4.05985476 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.05487783 |
| 13 | Aortic aneurysm (HP:0004942) | 3.90813363 |
| 14 | Shallow orbits (HP:0000586) | 3.83166277 |
| 15 | Wrist flexion contracture (HP:0001239) | 3.81826842 |
| 16 | Spinal rigidity (HP:0003306) | 3.81194606 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 3.64496705 |
| 18 | Fragile skin (HP:0001030) | 3.55615735 |
| 19 | Atrophic scars (HP:0001075) | 3.51998373 |
| 20 | Slender build (HP:0001533) | 3.42058485 |
| 21 | Mitral valve prolapse (HP:0001634) | 3.40001022 |
| 22 | Dilatation of the ascending aorta (HP:0005111) | 3.36073790 |
| 23 | Cervical subluxation (HP:0003308) | 3.32561301 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 3.29835403 |
| 25 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.29418115 |
| 26 | Bladder diverticulum (HP:0000015) | 3.24642359 |
| 27 | Striae distensae (HP:0001065) | 3.21246012 |
| 28 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.10085647 |
| 29 | Abnormality of complement system (HP:0005339) | 3.03497789 |
| 30 | Aortic valve stenosis (HP:0001650) | 2.99364891 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.84793262 |
| 32 | Vertebral compression fractures (HP:0002953) | 2.79118525 |
| 33 | Redundant skin (HP:0001582) | 2.77928875 |
| 34 | Hyporeflexia of lower limbs (HP:0002600) | 2.77420436 |
| 35 | Mitral stenosis (HP:0001718) | 2.74953961 |
| 36 | Lipoatrophy (HP:0100578) | 2.71273110 |
| 37 | Hypertriglyceridemia (HP:0002155) | 2.70415480 |
| 38 | Blue sclerae (HP:0000592) | 2.66664606 |
| 39 | Hyperextensible skin (HP:0000974) | 2.63238352 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62564178 |
| 41 | Osteolytic defects of the hand bones (HP:0009699) | 2.62564178 |
| 42 | Acanthosis nigricans (HP:0000956) | 2.61104834 |
| 43 | Difficulty running (HP:0009046) | 2.61043804 |
| 44 | Exercise-induced myalgia (HP:0003738) | 2.60250965 |
| 45 | Rectal prolapse (HP:0002035) | 2.56885969 |
| 46 | Alopecia of scalp (HP:0002293) | 2.54848970 |
| 47 | Aneurysm (HP:0002617) | 2.51321924 |
| 48 | Exercise-induced muscle cramps (HP:0003710) | 2.50683414 |
| 49 | Bowel diverticulosis (HP:0005222) | 2.44016315 |
| 50 | Back pain (HP:0003418) | 2.42274186 |
| 51 | Peritonitis (HP:0002586) | 2.39801723 |
| 52 | Pulmonary artery stenosis (HP:0004415) | 2.38444980 |
| 53 | Emphysema (HP:0002097) | 2.37644626 |
| 54 | Ovoid vertebral bodies (HP:0003300) | 2.36581523 |
| 55 | Limited hip movement (HP:0008800) | 2.35962286 |
| 56 | Sudden death (HP:0001699) | 2.35737410 |
| 57 | Ventricular tachycardia (HP:0004756) | 2.35713658 |
| 58 | Spondylolisthesis (HP:0003302) | 2.34739995 |
| 59 | Wormian bones (HP:0002645) | 2.34073267 |
| 60 | Myoglobinuria (HP:0002913) | 2.33776903 |
| 61 | Genu recurvatum (HP:0002816) | 2.30599808 |
| 62 | Joint laxity (HP:0001388) | 2.29156728 |
| 63 | Overgrowth (HP:0001548) | 2.28198749 |
| 64 | Venous abnormality (HP:0002624) | 2.22625228 |
| 65 | Thin bony cortex (HP:0002753) | 2.16971381 |
| 66 | Oligomenorrhea (HP:0000876) | 2.16373940 |
| 67 | Broad ribs (HP:0000885) | 2.15956988 |
| 68 | Neck muscle weakness (HP:0000467) | 2.15920107 |
| 69 | Vascular tortuosity (HP:0004948) | 2.13353267 |
| 70 | Generalized amyotrophy (HP:0003700) | 2.11675317 |
| 71 | Complement deficiency (HP:0004431) | 2.10505216 |
| 72 | Flat cornea (HP:0007720) | 2.09963667 |
| 73 | Mild short stature (HP:0003502) | 2.09502242 |
| 74 | Bone cyst (HP:0012062) | 2.09061215 |
| 75 | Spinal cord compression (HP:0002176) | 2.07854383 |
| 76 | Camptodactyly of toe (HP:0001836) | 2.07821061 |
| 77 | Venous insufficiency (HP:0005293) | 2.06521979 |
| 78 | Abnormality of the calf musculature (HP:0001430) | 2.06207316 |
| 79 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.04270461 |
| 80 | Infantile muscular hypotonia (HP:0008947) | 2.02755479 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 2.02070983 |
| 82 | Hematochezia (HP:0002573) | 1.96509550 |
| 83 | Polycythemia (HP:0001901) | 1.96364866 |
| 84 | Mitral regurgitation (HP:0001653) | 1.95704551 |
| 85 | Neoplasm of head and neck (HP:0012288) | 1.95313846 |
| 86 | Esophageal neoplasm (HP:0100751) | 1.95313846 |
| 87 | Abnormal delivery (HP:0001787) | 1.94731142 |
| 88 | Asymmetric septal hypertrophy (HP:0001670) | 1.92834707 |
| 89 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91201608 |
| 90 | Narrow nasal bridge (HP:0000446) | 1.89749722 |
| 91 | Tarsal synostosis (HP:0008368) | 1.89277688 |
| 92 | Aortic regurgitation (HP:0001659) | 1.88666643 |
| 93 | Biconcave vertebral bodies (HP:0004586) | 1.87328825 |
| 94 | Persistence of primary teeth (HP:0006335) | 1.87058650 |
| 95 | Ulnar deviation of the wrist (HP:0003049) | 1.86796277 |
| 96 | Gingival overgrowth (HP:0000212) | 1.86710632 |
| 97 | Bell-shaped thorax (HP:0001591) | 1.86240798 |
| 98 | Arterial tortuosity (HP:0005116) | 1.85787154 |
| 99 | Beaking of vertebral bodies (HP:0004568) | 1.85608665 |
| 100 | Wide anterior fontanel (HP:0000260) | 1.85603085 |
| 101 | Myocardial infarction (HP:0001658) | 1.84598447 |
| 102 | Myotonia (HP:0002486) | 1.84489223 |
| 103 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.84235246 |
| 104 | Elbow flexion contracture (HP:0002987) | 1.84134411 |
| 105 | Ectopia lentis (HP:0001083) | 1.84072160 |
| 106 | Neonatal short-limb short stature (HP:0008921) | 1.83907749 |
| 107 | Hip contracture (HP:0003273) | 1.83768232 |
| 108 | Lymphangioma (HP:0100764) | 1.83486956 |
| 109 | Abnormality of the acetabulum (HP:0003170) | 1.82045592 |
| 110 | Joint stiffness (HP:0001387) | 1.81672692 |
| 111 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.80836827 |
| 112 | Muscle fiber inclusion bodies (HP:0100299) | 1.80806326 |
| 113 | Disproportionate tall stature (HP:0001519) | 1.80194728 |
| 114 | Skin nodule (HP:0200036) | 1.79962593 |
| 115 | Osteoarthritis (HP:0002758) | 1.79201319 |
| 116 | EMG: myopathic abnormalities (HP:0003458) | 1.78104501 |
| 117 | Rhabdomyolysis (HP:0003201) | 1.76561913 |
| 118 | Delayed cranial suture closure (HP:0000270) | 1.76442991 |
| 119 | Hypoplasia of the iris (HP:0007676) | 1.75866877 |
| 120 | Small epiphyses (HP:0010585) | 1.75548417 |
| 121 | Insulin resistance (HP:0000855) | 1.75500346 |
| 122 | Limb-girdle muscle weakness (HP:0003325) | 1.74859531 |
| 123 | Hyperlipoproteinemia (HP:0010980) | 1.74128787 |
| 124 | Atrial fibrillation (HP:0005110) | 1.73293195 |
| 125 | Hypercortisolism (HP:0001578) | 1.71613206 |
| 126 | Facial diplegia (HP:0001349) | 1.70774187 |
| 127 | Hypoplasia of the odontoid process (HP:0003311) | 1.69647532 |
| 128 | Breech presentation (HP:0001623) | 1.67329279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.31374821 |
| 2 | TTN | 3.95730172 |
| 3 | TGFBR2 | 2.99151231 |
| 4 | CAMK1D | 2.86168726 |
| 5 | ERN1 | 2.79764093 |
| 6 | SIK1 | 2.70070312 |
| 7 | PDGFRA | 2.64017728 |
| 8 | DDR2 | 2.49663966 |
| 9 | MYLK | 2.47528572 |
| 10 | RIPK1 | 2.41013668 |
| 11 | TESK1 | 2.19589856 |
| 12 | TIE1 | 2.16955729 |
| 13 | BCKDK | 2.10811629 |
| 14 | LMTK2 | 2.03840218 |
| 15 | CAMK1G | 2.03573201 |
| 16 | OBSCN | 1.98166732 |
| 17 | PDK3 | 1.93454490 |
| 18 | PDK4 | 1.93454490 |
| 19 | EPHB2 | 1.91663476 |
| 20 | MST1R | 1.91059970 |
| 21 | DMPK | 1.83924968 |
| 22 | PHKG1 | 1.83374909 |
| 23 | PHKG2 | 1.83374909 |
| 24 | LATS1 | 1.83169899 |
| 25 | FER | 1.59799568 |
| 26 | ABL2 | 1.59138793 |
| 27 | STK24 | 1.59107069 |
| 28 | STK38L | 1.58359534 |
| 29 | PDK2 | 1.56374234 |
| 30 | EPHA3 | 1.54553168 |
| 31 | FGFR4 | 1.50920940 |
| 32 | CAMK1 | 1.49137662 |
| 33 | PKN2 | 1.47631558 |
| 34 | EPHB1 | 1.47388975 |
| 35 | PIK3CA | 1.42534988 |
| 36 | LATS2 | 1.41899868 |
| 37 | MAPK7 | 1.22343720 |
| 38 | FGFR3 | 1.22160486 |
| 39 | JAK1 | 1.19438387 |
| 40 | TRPM7 | 1.15727784 |
| 41 | FGFR2 | 1.13638871 |
| 42 | MET | 1.11632536 |
| 43 | ILK | 1.09820350 |
| 44 | MAPK4 | 1.07281352 |
| 45 | NEK9 | 1.04991377 |
| 46 | PDGFRB | 1.04111785 |
| 47 | PRKCH | 1.02927652 |
| 48 | ADRBK1 | 1.02452419 |
| 49 | INSRR | 0.99465712 |
| 50 | PRKAA2 | 0.98549780 |
| 51 | FRK | 0.98449074 |
| 52 | PIK3CG | 0.98212037 |
| 53 | PTK6 | 0.98019051 |
| 54 | PAK2 | 0.94373524 |
| 55 | STK3 | 0.91426949 |
| 56 | PRKD1 | 0.89441178 |
| 57 | MAP3K3 | 0.85817938 |
| 58 | MARK2 | 0.84974186 |
| 59 | MAP3K7 | 0.82636613 |
| 60 | GRK5 | 0.78988599 |
| 61 | PRPF4B | 0.78358505 |
| 62 | BMX | 0.77853951 |
| 63 | MOS | 0.76748903 |
| 64 | PTK2B | 0.75140696 |
| 65 | PINK1 | 0.74887519 |
| 66 | PKN1 | 0.72735091 |
| 67 | LIMK1 | 0.72504328 |
| 68 | MAP2K1 | 0.71135520 |
| 69 | PRKD2 | 0.70303475 |
| 70 | ROCK1 | 0.69919438 |
| 71 | LRRK2 | 0.68524197 |
| 72 | STK38 | 0.68248707 |
| 73 | PRKG1 | 0.65710477 |
| 74 | RPS6KA2 | 0.65620016 |
| 75 | CSK | 0.65441758 |
| 76 | FGFR1 | 0.64478538 |
| 77 | GSK3A | 0.64199633 |
| 78 | MAPKAPK3 | 0.62408216 |
| 79 | MAP2K3 | 0.60363759 |
| 80 | MTOR | 0.59761510 |
| 81 | MAP3K6 | 0.57144326 |
| 82 | HIPK2 | 0.52964333 |
| 83 | MAP3K13 | 0.52385827 |
| 84 | TGFBR1 | 0.51862488 |
| 85 | PRKG2 | 0.51737839 |
| 86 | ARAF | 0.51641806 |
| 87 | CAMK2G | 0.50540585 |
| 88 | PAK4 | 0.50538820 |
| 89 | JAK3 | 0.50432313 |
| 90 | JAK2 | 0.50249027 |
| 91 | NLK | 0.49685004 |
| 92 | MAPK12 | 0.49246013 |
| 93 | PAK3 | 0.49236096 |
| 94 | PTK2 | 0.48310580 |
| 95 | SGK2 | 0.47978540 |
| 96 | CDK6 | 0.47743949 |
| 97 | EEF2K | 0.46128778 |
| 98 | TYK2 | 0.45967694 |
| 99 | ERBB3 | 0.45140664 |
| 100 | CAMKK2 | 0.44361948 |
| 101 | RET | 0.43753807 |
| 102 | SGK494 | 0.43742177 |
| 103 | SGK223 | 0.43742177 |
| 104 | SGK3 | 0.42333818 |
| 105 | DAPK3 | 0.41382825 |
| 106 | PRKAA1 | 0.40996759 |
| 107 | MAPK3 | 0.38360425 |
| 108 | ABL1 | 0.38256888 |
| 109 | FLT3 | 0.38103500 |
| 110 | PRKD3 | 0.37981133 |
| 111 | RPS6KL1 | 0.37187268 |
| 112 | RPS6KC1 | 0.37187268 |
| 113 | KDR | 0.37024378 |
| 114 | NTRK1 | 0.36811013 |
| 115 | ROCK2 | 0.36374525 |
| 116 | IGF1R | 0.33184694 |
| 117 | INSR | 0.32698971 |
| 118 | KIT | 0.32581640 |
| 119 | SRC | 0.31673984 |
| 120 | MAP2K2 | 0.30544294 |
| 121 | PRKCE | 0.29045304 |
| 122 | CDC42BPA | 0.28765845 |
| 123 | PRKACG | 0.28153943 |
| 124 | PIM2 | 0.27178646 |
| 125 | PDPK1 | 0.26115607 |
| 126 | CDK9 | 0.21748369 |
| 127 | ZAP70 | 0.21298487 |
| 128 | CAMK4 | 0.21073632 |
| 129 | MAPK11 | 0.20460871 |
| 130 | TBK1 | 0.19459772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.59288087 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.88352367 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.62621594 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.61273455 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.61107495 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.54203246 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.32518504 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25342225 |
| 9 | Focal adhesion_Homo sapiens_hsa04510 | 2.25233631 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.18621445 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.12644797 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.08525622 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92442842 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84860091 |
| 15 | Amoebiasis_Homo sapiens_hsa05146 | 1.84123491 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83314363 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.75063055 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.74068068 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.72369205 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.66372289 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.47177316 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39985959 |
| 23 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.33276779 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30537908 |
| 25 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.30158665 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29278704 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22120817 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15654516 |
| 29 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13007230 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07617104 |
| 31 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.07203284 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06057703 |
| 33 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02518210 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.02266875 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01819832 |
| 36 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.01240924 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01054670 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00996500 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00980416 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00852496 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99240772 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98921289 |
| 43 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97975014 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96977839 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93338144 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83826844 |
| 47 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81254863 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 0.75600152 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75537405 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74964577 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.74935016 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73233816 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73097249 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71067391 |
| 55 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70529798 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69502140 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69219883 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.67599341 |
| 59 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67144122 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66378614 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65273355 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63791203 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63421978 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61488276 |
| 65 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61402704 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61155459 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60101403 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59217853 |
| 69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59144336 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58736551 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56400813 |
| 72 | Gap junction_Homo sapiens_hsa04540 | 0.55966651 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55866318 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55853660 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.55154393 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54596479 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54391228 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.53644388 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52677845 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52619561 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52399283 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51691097 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51596885 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51561364 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51485538 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51169645 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.50270562 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.49445201 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49199587 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48738686 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47571919 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46811959 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46251089 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.45975480 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.45395668 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45273687 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45136572 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.45107372 |
| 99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.44644857 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.43751914 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42186559 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42144008 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41607996 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41264792 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41237689 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40476012 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.39118232 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.37813663 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37654585 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35656267 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35507552 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35478945 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34836441 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34739327 |
| 115 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34621719 |
| 116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33550107 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.33346513 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32944014 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32537788 |
| 120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31856717 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31356571 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31039980 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.30734739 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30520622 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30312726 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30097138 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30074725 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29752203 |
| 129 | Axon guidance_Homo sapiens_hsa04360 | 0.28611395 |
| 130 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.28556433 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27568218 |
| 132 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27308972 |

